Rachel L. Epstein, MD, MScE
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

MD, Thomas Jefferson University
MSc, Boston University School of Public Health
MA, Wesleyan University
BA, Wesleyan University

Pronouns: she/her/hers



Rachel L. Epstein, MD, MScE, is a clinician-scientist working to utilize large data sets and decision modelling to inform policy and program design to improve care for individuals with Hepatitis C, HIV, and substance use, with a particular focus on pregnant women and youth.

Dr. Epstein completed combined residency training in internal medicine-pediatrics at Brown University, and worked in primary care through the Providence Community Health Centers and the Hasbro Adolescent Center before fellowship. She completed a combined adult and pediatric infectious diseases fellowship at Boston Medical Center and a T32 post-doctoral research fellowship through the Boston University Clinical HIV/AIDS Research Training Program (BU-CHART). She is an Assistant Professor in the BUSM Department of Medicine, Section of Infectious Diseases, and Department of Pediatrics, Section of Infectious Diseases and sees adult and pediatric patients living with or at risk for Hepatitis C virus, HIV, and other infectious diseases. She also serves as the Med-Peds faculty specific advisor lead for BUSM students.

Dr. Epstein's current and recent work includes projects analyzing the effects of Medicaid HCV treatment restrictions on care cascade outcome achievement, HIV prevention and medication adherence, and comparing the cost-effectiveness of HCV and OUD screening, evaluation, and treatment interventions in women of reproductive age, children, and the general population. She currently or previously works/worked with data through OCHIN, TriNetX, the BMC Datawarehouse and COVID-19 Repository, Marketscan, and the Massachusetts Public Health Datawarehouse.

Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Pediatrics





Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
07/01/2022 - 06/30/2027 (PI)
National Institute on Drug Abuse/NIH/DHHS
5K01DA052821-02

Administrative Supplement to Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
07/01/2024 - 06/30/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3K01DA052821-03S1

Cost-effectiveness and Clinical Outcomes of Liver Disease Staging Evaluations in Chronic Hepatitis C Virus Infection: Strategies to Increase Hepatitis C Treatment Access and Achieve HCV Elimination
01/01/2022 - 12/31/2024 (PI)
The Patrick and Catherine Weldon Donaghue Medical Research Foundation

Postdoctoral Research Fellowship Program
12/01/2020 - 11/30/2022 (PI)
Charles A. King Trust

Medicaid State Hepatitis C Treatment Restrictions: Spillover Effects on the Care Cascade
05/01/2019 - 04/30/2021 (Subcontract PI)
PI: Rachel L. Epstein, MD, MScE
Weill Cornell Medical College NIH NIDA
2P30DA040500-06A1


Title


Yr Title Project-Sub Proj Pubs
2024 Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) 3K01DA052821-03S1
2024 Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) 5K01DA052821-03
2023 Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) 5K01DA052821-02
2022 Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) 1K01DA052821-01A1

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Epstein RL, Kurnellas A, Munroe S, Curtis MR, Biondi B, Wachman EM. Racial and Ethnic Disparities in Testing of Hepatitis C Virus-Exposed Children Across the United States. J Pediatric Infect Dis Soc. 2024 Nov 21; 13(Supplement_5):S159-S165.View Related Profiles. PMID: 39171788
     
  2. Jhaveri R, Epstein R, Thompson P. Viral Hepatitis Elimination in Infants, Children, and Pregnancy: Elimination for Everyone by Everyone. J Pediatric Infect Dis Soc. 2024 Nov 21; 13(Supplement_5):S137-S138. PMID: 39570896
     
  3. Epstein RL, Munroe S, Taylor LE, Duryea PR, Buzzee B, Pramanick T, Feld JJ, Baptiste D, Carroll M, Castera L, Sterling RK, Thomas A, Chan PA, Linas BP. Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study. Clin Infect Dis. 2024 Nov 13.View Related Profiles. PMID: 39535186
     
  4. Curtis MR, Epstein RL, Pei P, Linas BP, Ciaranello AL. Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus. JAMA Pediatr. 2024 May 01; 178(5):489-496.View Related Profiles. PMID: 38466273; PMCID: PMC10928541; DOI: 10.1001/jamapediatrics.2024.0114;
     
  5. Epstein RL, Buzzee B, White LF, Feld JJ, Castera L, Sterling RK, Linas BP, Taylor LE. Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus. J Viral Hepat. 2024 Jun; 31(6):277-292.View Related Profiles. PMID: 38326950; PMCID: PMC11102317; DOI: 10.1111/jvh.13925;
     
  6. Epstein RL, Pramanick T, Baptiste D, Buzzee B, Reese PP, Linas BP, Sawinski D. A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus Screening Frequencies in Hemodialysis Centers. J Am Soc Nephrol. 2023 Feb 01; 34(2):205-219.View Related Profiles. PMID: 36735375; PMCID: PMC10103100; DOI: 10.1681/ASN.2022030245;
     
  7. Lodi S, Klein M, Rauch A, Epstein R, Wittkop L, Logan R, Rentsch CT, Justice AC, Touloumi G, Berenguer J, Jarrin I, Egger M, Puoti M, D'Arminio Monforte A, Gill J, Salmon Ceron D, van Sighem A, Linas B, van der Valk M, Hernán MA. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection. J Int AIDS Soc. 2022 Dec; 25(12):e26048.View Related Profiles. PMID: 36562643; PMCID: PMC9784654; DOI: 10.1002/jia2.26048;
     
  8. Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 Aug 24; 75(1):e1112-e1119.View Related Profiles. PMID: 34499124; PMCID: PMC8522427; DOI: 10.1093/cid/ciab779;
     
  9. Sperring H, Hofman M, Hsu HE, Xiao Y, Keohane EA, Lodi S, Marathe J, Epstein RL. Risk Factors for Admission Within a Hospital-Based COVID-19 Home Monitoring Program. Open Forum Infect Dis. 2022 Jul; 9(7):ofac320.View Related Profiles. PMID: 35899280; PMCID: PMC9278211; DOI: 10.1093/ofid/ofac320;
     
  10. Epstein RL, Wang J, White LF, Kapadia SN, Morgan JR, Bao Y, Linas BP. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured. Am J Prev Med. 2022 Sep; 63(3):e87-e98.View Related Profiles. PMID: 35725599; PMCID: PMC9676070; DOI: 10.1016/j.amepre.2022.03.010;
     
Showing 10 of 23 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 23 publications over 8 distinct years, with a maximum of 6 publications in 2022

YearPublications
20171
20181
20193
20201
20215
20226
20231
20245

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

Q&A: How to improve HCV care among women who use opioids

Healio 11/5/2024

Disparities in Hepatitis C Care for Reproductive-Aged Women

Technology Networks 10/8/2024

Revealing disparities in hepatitis C care for reproductive-aged women to break cycle of viral transmission

Medical Xpress 10/7/2024

New HCV testing guidelines aim to increase screening among exposed infants

Healio 9/20/2024

Projected Long-Term Impact of the COVID-19 Pandemic on Outcomes Associated With Hepatitis C Virus

Infection Disease Advisor 10/7/2021

Linkage to Care Leads to More Hepatitis C Treatment for Pregnant Women

HCP Live 7/8/2021

Comorbidities May Result in Longer Duration of Positive COVID-19 PCR Tests

Contagion Live 6/17/2021

Few Perinatally Exposed Infants Receive Recommended Hep C Testing

M.D. alert 2/14/2020

Only 30% of Youths with Identified Substance Use Tested for HCV

Healio 12/11/2019

Researchers Call for Greater Hep C Screening for Young Drug Users

Addiction Professional 12/10/2019

Why Aren't More Users Of Opioids Or Meth Screened For Hepatitis C?

NPR 12/19/2018

Finding and Treating the Young Hepatitis C Patient

MD Magazine 12/3/2018

Universal HCV Screening on the Way?

MedPage Today 11/9/2018

Only One-Third of Opioid-Addicted Teens and Young Adults Get Tested for HCV

MD Magazine 10/19/2018
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Hepatitis C virus
Human Immunodeficiency Virus
Substance Use Disorders
Pediatric HCV
Decision Modeling
Opioid Use
Health Policy
Pediatric HIV
PrEP
Screening, Prenatal
Contact for Mentoring:

617.414.5295
Download vCard

Epstein's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (89) concept(s)
_
Media Mentions
_
Co-Authors
See all (26) people
_
Similar People
See all (60) people
_
Same Department
Search Department